Treating diabetes

Jan 29, 2010
Treating diabetes

(PhysOrg.com) -- Uncontrolled high blood glucose levels in patients with diabetes (hyperglycaemia) is known to increase mortality, but new research led by the University shows that intensive treatment to control blood glucose can lower it too far (hypoglycaemia), which also increases mortality. Thus, blood glucose level targets should have lower as well as upper limits to lower risk to patients.

The findings are reported in an article published in The Lancet, written by Dr Craig Currie of the School of Medicine and colleagues.

The study also found that patients with given insulin-based treatments had a 50% increased mortality risk compared to those given combination oral therapy.

The specific goal for control of blood sugar is to return glycated haemoglobin - the glucose level in blood over a prolonged period of time - to a normal range. Good blood sugar (glycaemic) control is known to reduce risk of long-term small blood vessel complications in both type 1 and type 2 diabetes.

Explaining the need for the research, Dr Currie said: “Reports of potentially raised mortality rates associated with intensive blood sugar control have triggered discussion about recommendations for treatment of type 2 diabetes, specifically relating to the optimum target for glycated haemoglobin. Researchers have suggested that hypoglycaemia contributes to a heightened risk of mortality in patients with diabetes. Because intensive control increases risk of hypoglycaemia with some drugs more than with others, assessment of risks associated with the different blood glucose-lowering regimens is important.”

The research assessed the association between all-cause mortality and glycated haemoglobin in patients with type 2 diabetes in a primary care setting and aimed to establish whether any evident association was independent of the diabetes treatment regimen.

Two cohorts of patients aged 50 years and older with type 2 diabetes were generated from the UK General Practice Research Database from November 1986 to November 2008. The researchers identified 27,965 patients whose treatment had been intensified from oral monotherapy to combination therapy with oral lowering agents (metformin plus sulphonylurea), and 20,005 who had changed to treatments that included insulin.

Those with diabetes secondary to other causes were excluded. All-cause mortality was the primary outcome. Age, sex, smoking status, cholesterol, cardiovascular risk, and general morbidity were identified as important confounding factors, and the data were subsequently adjusted for these factors.

Commenting on the findings Dr Currie said: “While the data suggest that insulin could increase the risk of death in type 2 diabetes, differences in the baseline characteristics of the insulin treated patients, such as being older, other medical conditions, longer duration of diabetes, could be behind part of all of this increased risk.

“Whether intensification of glucose control with insulin therapy alone further heightens risk of death in patients with diabetes needs further investigation and assessment of the overall risk balance.

“Low and high mean glycated haemoglobin values were associated with increased all-cause mortality and cardiac events. If confirmed, guidelines might need revision to include a minimum value.”

Explore further: Duncan kin, some at hospital near end of Ebola isolation

Related Stories

Self-monitoring of blood glucose

Sep 29, 2009

Diabetes patients should always control their own blood sugar values if this leads to improvements in their treatment. This is the view advocated by Michael Nauck of the Bad Lauterberg Diabetes Center and his coauthors in ...

FDA approves new diabetes treatment

Oct 17, 2006

The U.S. Food and Drug Administration has approved the use of Januvia tablets as the first in a new class of diabetes drugs.

Intensive glucose control in diabetics reduces heart attacks

May 26, 2009

(PhysOrg.com) -- A meta-analysis of five trials has shown that more intensive glucose control in diabetes leads to fewer heart attacks and heart disease events - but has no significant effect on stroke or mortality from all ...

Recommended for you

Ebola: Five questions about the killer virus

42 minutes ago

The highly contagious Ebola virus, which has killed more than 4,500 people in west Africa since December and has fueled global alarm, is among the most dangerous ever identified.

Ebola fear, monitoring eases for some in Dallas

52 minutes ago

The people closest to Ebola victim Thomas Eric Duncan are trying to resume their lives now that they have come out of a 21-day incubation period without developing symptoms of the disease.

Third UN employee dies from Ebola

1 hour ago

A UN staff member in Sierra Leone has died from Ebola, the third employee from the world organization to succumb to the deadly virus, the UN spokesman said Monday.

Canadian Ebola vaccine sent to WHO for testing

1 hour ago

The first batch of an experimental Ebola vaccine developed by Canadian scientists was sent to Switzerland on Monday for testing by the World Health Organization, officials said.

User comments : 0